Afrigen creates COVID vaccine using Moderna data

15-02-2022

Alex Baldwin

Afrigen creates COVID vaccine using Moderna data

Ralf Liebhold / Shutterstock.com

Afrigen Biologics has used the publicly available information relating to Moderna’s COVID-19 vaccine to manufacture its own version of the treatment, which could see testing by the end of this year.


Afrigen, South Africa, IP, patents, WHO, Moderna, Pfizer, COVID-19, generics

LSIPR